Social networks
4,272Activities
Technologies
Entity types
Location
Bertel Jungin aukio 1, 02600 Espoo, Finland
Espoo
Finland
Employees
Scale: 11-50
Estimated: 21
Engaged corporates
1Added in Motherbase
3 months, 2 weeks agoHerantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s.
Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease. Herantis’ lead product HER-096, is an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein. It combines the compelling mechanism of action of CDNF with the convenience of subcutaneous administration. A Phase 1a clinical trial has demonstrated a good safety and tolerability profile, and efficient blood-brain barrier penetration of subcutaneously administered HER-096 in humans. The shares of Herantis are listed on the Nasdaq First North Growth Market Finland.
Parkinson's disease, Neurodegenerative diseases, Biologics, biotech, and drug development
Herantis Pharma is a publicly listed drug development company aiming to revolutionize the treatment of diseases with unmet clinical needs.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
PharmaTimes Media Ltd Pharmaceutical, Pharmaceutical Manufacturing | PharmaTimes Media Ltd Pharmaceutical, Pharmaceutical Manufacturing | Other 7 Jul 2024 | |